Cooperative Agreement 2129152

This Project Grant awarded by the National Cancer Institute (NCI), under the federal Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $399,789 to Ergami Endoscopy, Inc. to develop an automated robotic flexible overtube device capable of blind insertion during colonoscopy procedures. The device aims to reduce physician injuries, improve productivity, and decrease patient pain/sedation requirements for the over 16 million colonoscopies performed annually in the U.S. Key...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,990 to Scorpido Photonics aims to develop a prototype endoscope-based diagnostic system for rapid, non-invasive detection of microscopic tumors. The project integrates plasmonic nanobubble sensors into a medical device platform and standard endoscope to enable instant, optical detection of cancerous tissues during lung cancer diagnostic procedures. The key product is a...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $1,250,000 to Biodevek Inc., a small business, aims to develop a novel sprayable hydrogel sealant for managing gastrointestinal (GI) lesions and bleeding. The project focuses on advancing the hydrogel delivery system to seamlessly integrate with endoscopic procedures, addressing technical challenges such as optimizing catheter design, preventing clogging, and ensuring...

This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $192,168 to The Regents of the University of Colorado to develop a miniaturized optical coherence tomography (MOCT) endoscope system with an integrated electrowetting prism scanner. The key objectives are to: 1) Demonstrate a low-voltage, high-speed electrowetting prism...

The National Science Foundation awarded Pensievision, Inc. $255,947 under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an endoscopic 3D imaging system for evaluating cancers and disorders of the esophagus and pharynx. The Small Business Innovation Research Phase I project will combine liquid lens technology, artificial intelligence software, and astronomical imaging techniques to generate three-dimensional images of early-stage esophageal and throat tumors....

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant awarded $274,440 to Vine Medical Inc., a for-profit manufacturing company, to develop a proof-of-concept for a self-deploying endotracheal intubation device. The proposed soft robotics system aims to achieve over a 90% first-pass intubation success rate, which would improve patient outcomes and reduce complications during emergency airway management procedures. The device is designed to...

This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $994,138 to Modendo Inc., a for-profit company located in Boulder, CO, to develop and validate a prototype ultrathin endomicroscope instrument for high-resolution, minimally invasive optical imaging of the brain in animal neuroscience research. The key innovation is achieving a cross-sectional area more than 10 times smaller than...

Modendo Inc. received a $256,000 Small Business Innovation Research Phase I Project Grant from the National Science Foundation to develop an ultrathin endomicroscope. The grant was awarded under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to advance science and engineering research leading to breakthrough technologies. Specifically, the funding will support Modendo's development of a new class of minimally invasive endoscope probes with diameters as small as 100...

This $999,783 Phase II Small Business Innovation Research (SBIR) cooperative agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports Intact Therapeutics' development of a thermogel-based drug delivery platform for the treatment of upper gastrointestinal bleeding (UGIB). Intact Therapeutics' proprietary thermogel technology aims to rapidly stop UGIB prior to endoscopic treatment, potentially reducing patient morbidity,...

The National Science Foundation awarded a $256,000 Small Business Technology Transfer Phase I Project Grant to develop a minimally invasive articulating intubation stylet. The grant period runs from June 15, 2021 through May 31, 2022 under the Engineering (47.041) program. This program aims to foster innovation and excellence in engineering research and education across various fields. Funds will support the awardee, located in Blaine, Minnesota, to research and develop a new medical device...